T1	tradename 0 6	BEXXAR
T3	activeingredient 8 19	tositumomab
T5	nanoparticle 24 49	iodine I 131 tositumomab)
T7	tradename 157 163	BEXXAR
T9	tradename 226 241	BEXXAR. BEXXAR
T11	activeingredient 243 254	tositumomab
T13	nanoparticle 259 284	iodine I 131 tositumomab)
T15	routeofadministration 300 311	intravenous
T17	fdaapprovaldate 344 348	2003
T19	adversereaction 528 547	Allergic Reactions:
T21	tradename 611 617	BEXXAR
T23	adversereaction 650 668	allergic reactions
T25	tradename 733 739	BEXXAR
T27	tradename 935 941	BEXXAR
T29	tradename 1550 1556	BEXXAR
T31	activeingredient 1558 1569	tositumomab
T33	nanoparticle 1574 1599	Iodine I 131 tositumomab)
T35	chemoclass 1605 1618	CD20-directed
T37	indication 1768 1786	Hodgkin's lymphoma
T39	indication 1887 1910	non-Hodgkin's lymphoma.
T41	tradename 1960 1966	BEXXAR
T43	tradename 2113 2119	BEXXAR
T45	tradename 2202 2208	BEXXAR
T47	tradename 2408 2414	BEXXAR
T49	tradename 2603 2603	
T51	activeingredient 2603 2614	Tositumomab
T53	tradename 2668 2668	
T55	activeingredient 2668 2679	Tositumomab
T57	tradename 2732 2732	
T59	nanoparticle 2732 2756	Iodine I 131 tositumomab
T61	activeingredient 2787 2797	Iodine-131
T63	activeingredient 2869 2880	tositumomab
T65	tradename 2942 2942	
T67	nanoparticle 2942 2966	Iodine I 131 tositumomab
T69	activeingredient 2999 3009	Iodine-131
T71	activeingredient 3078 3089	tositumomab
T73	tradename 3496 3502	BEXXAR
T75	adversereaction 4127 4138	neutropenia
T77	adversereaction 4140 4156	thrombocytopenia
T79	adversereaction 4158 4164	anemia
T81	adversereaction 4166 4176	infections
T83	adversereaction 4178 4196	infusion reactions
T85	adversereaction 4198 4206	asthenia
T87	adversereaction 4208 4213	fever
T89	adversereaction 4219 4226	nausea.
T91	tradename 4280 4280	
T93	company 4280 4295	GlaxoSmithKline
T95	tradename 6623 6629	BEXXAR
T97	tradename 6766 6772	BEXXAR
T99	tradename 6945 6951	BEXXAR
T101	tradename 7097 7103	BEXXAR
T103	tradename 7391 7397	BEXXAR
T105	tradename 7527 7533	BEXXAR
T107	tradename 7825 7831	BEXXAR
T109	indication 7961 7983	Non-Hodgkin's Lymphoma
T111	tradename 7989 7995	BEXXAR
T113	nanoparticle 8018 8029	tositumomab
T115	activeingredient 8034 8046	iodine I 131
T117	nanoparticle 8047 8059	tositumomab)
T119	indication 8184 8206	non-Hodgkin's lymphoma
T121	indication 8307 8330	non-Hodgkin's lymphoma.
T123	tradename 8375 8381	BEXXAR
T125	tradename 8528 8534	BEXXAR
T127	tradename 8623 8629	BEXXAR
T129	tradename 8756 8762	BEXXAR
T131	tradename 8815 8821	BEXXAR
T133	indication 8918 8941	non-Hodgkin's lymphoma.
T135	tradename 8977 8983	BEXXAR
T137	nanoparticle 9039 9050	tositumomab
T139	activeingredient 9058 9070	iodine I 131
T141	nanoparticle 9071 9083	tositumomab)
T143	nanoparticle 9449 9460	Tositumomab
T145	dose 9461 9467	450 mg
T147	routeofadministration 9471 9482	intravenous
T149	nanoparticle 9499 9516	I-131 tositumomab
T151	dose 9518 9529	5 mCi I-131
T153	routeofadministration 9552 9563	intravenous
T155	nanoparticle 9650 9661	Tositumomab
T157	dose 9662 9668	450 mg
T159	routeofadministration 9672 9683	intravenous
T161	nanoparticle 9701 9718	I-131 tositumomab
T163	dose 9720 9726	35 mg)
T165	routeofadministration 9730 9741	intravenous
T167	activeingredient 9756 9766	iodine-131
T169	activeingredient 10062 10072	Iodine-131
T171	activeingredient 10232 10242	Iodine-131
T173	nanoparticle 10342 10353	Tositumomab
T175	nanoparticle 10540 10551	tositumomab
T177	dose 10573 10579	450 mg
T179	nanoparticle 10580 10591	tositumomab
T181	nanoparticle 10793 10804	tositumomab
T183	nanoparticle 10922 10933	tositumomab
T185	nanoparticle 11062 11079	I-131 Tositumomab
T187	nanoparticle 11334 11351	I-131 tositumomab
T189	nanoparticle 11442 11459	I-131 tositumomab
T191	nanoparticle 11583 11600	I-131 tositumomab
T193	nanoparticle 11801 11818	I-131 tositumomab
T195	activeingredient 12079 12090	Iodine-131.
T197	nanoparticle 12300 12317	I-131 tositumomab
T199	nanoparticle 12423 12440	I-131 tositumomab
T201	nanoparticle 12566 12577	tositumomab
T203	nanoparticle 12673 12690	I-131 tositumomab
T205	nanoparticle 12808 12819	tositumomab
T207	nanoparticle 12897 12908	tositumomab
T209	tradename 13920 13921	 
T211	nanoparticle 13921 13932	Tositumomab
T213	dose 14083 14089	450 mg
T215	nanoparticle 14090 14101	tositumomab
T217	routeofadministration 14135 14146	intravenous
T219	tradename 14599 14600	 
T221	nanoparticle 14600 14611	Tositumomab
T223	activeingredient 14661 14666	I-131
T225	nanoparticle 14667 14678	tositumomab
T227	activeingredient 14836 14841	I-131
T229	nanoparticle 14842 14853	tositumomab
T231	activeingredient 14912 14917	I-131
T233	nanoparticle 14918 14929	tositumomab
T235	nanoparticle 14987 14998	tositumomab
T237	activeingredient 15323 15328	I-131
T239	nanoparticle 15329 15340	tositumomab
T241	activeingredient 15905 15910	I-131
T243	nanoparticle 15911 15922	tositumomab
T245	activeingredient 15989 16001	Iodine I-131
T247	nanoparticle 16002 16013	tositumomab
T249	activeingredient 16253 16258	I-131
T251	nanoparticle 16260 16271	tositumomab
T253	company 16344 16359	GlaxoSmithKline
T255	nanoparticle 16558 16569	tositumomab
T257	company 18471 18486	GlaxoSmithKline
T259	tradename 18487 18493	BEXXAR
T261	company 18658 18673	GlaxoSmithKline
T263	activeingredient 18777 18787	Iodine-131
T265	tradename 18898 18898	
T267	nanoparticle 18898 18909	Tositumomab
T269	dose 18913 18919	450-mg
T271	nanoparticle 18928 18939	tositumomab
T273	tradename 19023 19024	 
T275	nanoparticle 19025 19042	I-131 tositumomab
T277	nanoparticle 19260 19277	I-131 tositumomab
T279	nanoparticle 19367 19384	I-131 tositumomab
T281	activeingredient 19506 19511	I-131
T283	nanoparticle 19512 19523	tositumomab
T285	activeingredient 19691 19696	I-131
T287	nanoparticle 19697 19708	tositumomab
T289	activeingredient 19876 19881	I-131
T291	nanoparticle 19882 19893	tositumomab
T293	activeingredient 20151 20162	Iodine-131.
T295	activeingredient 20406 20411	I-131
T297	nanoparticle 20412 20423	tositumomab
T299	activeingredient 20536 20541	I-131
T301	nanoparticle 20542 20553	tositumomab
T303	activeingredient 20602 20607	I-131
T305	nanoparticle 20612 20623	tositumomab
T307	nanoparticle 20715 20726	tositumomab
T309	activeingredient 20810 20815	I-131
T311	nanoparticle 20816 20827	tositumomab
T313	nanoparticle 20925 20936	tositumomab
T315	nanoparticle 20996 21007	tositumomab
T317	nanoparticle 21103 21114	tositumomab
T319	tradename 21661 21661	
T321	nanoparticle 21661 21672	Tositumomab
T323	dose 21811 21817	450 mg
T325	nanoparticle 21818 21829	tositumomab
T327	routeofadministration 21863 21874	intravenous
T329	tradename 22314 22315	 
T331	activeingredient 22315 22320	I-131
T333	nanoparticle 22321 22332	Tositumomab
T335	activeingredient 22379 22384	I-131
T337	nanoparticle 22385 22396	tositumomab
T339	activeingredient 22548 22553	I-131
T341	nanoparticle 22554 22565	tositumomab
T343	activeingredient 22620 22625	I-131
T345	nanoparticle 22626 22637	tositumomab
T347	nanoparticle 22695 22706	tositumomab
T349	activeingredient 23024 23029	I-131
T351	nanoparticle 23030 23041	tositumomab
T353	activeingredient 23606 23611	I-131
T355	nanoparticle 23612 23623	tositumomab
T357	activeingredient 23693 23705	Iodine I-131
T359	nanoparticle 23706 23717	tositumomab
T361	activeingredient 23904 23909	I-131
T363	nanoparticle 23910 23921	tositumomab
T365	tradename 24198 24204	BEXXAR
T367	tradename 24308 24314	BEXXAR
T369	tradename 24355 24361	BEXXAR
T371	tradename 25155 25156	 
T373	nanoparticle 25156 25167	Tositumomab
T375	nanoparticle 25217 25228	Tositumomab
T377	nanoparticle 25283 25294	tositumomab
T379	activeingredient 25325 25335	Iodine-131
T381	nanoparticle 25438 25449	tositumomab
T383	nanoparticle 25538 25549	tositumomab
T385	activeingredient 25582 25592	Iodine-131
T387	nanoparticle 25692 25703	tositumomab
T389	tradename 25903 25909	BEXXAR
T391	tradename 26449 26455	BEXXAR
T393	tradename 26579 26585	BEXXAR
T395	tradename 26720 26726	BEXXAR
T397	tradename 27121 27127	BEXXAR
T399	tradename 27342 27348	BEXXAR
T401	activeingredient 27378 27389	Iodine-131.
T403	tradename 27552 27558	BEXXAR
T405	tradename 27748 27754	BEXXAR
T407	tradename 27902 27908	BEXXAR
T409	tradename 27964 27970	BEXXAR
T411	tradename 28164 28170	BEXXAR
T413	tradename 28525 28531	BEXXAR
T415	tradename 28757 28763	BEXXAR
T417	tradename 28861 28867	BEXXAR
T419	tradename 29433 29439	BEXXAR
T421	tradename 29652 29658	BEXXAR
T423	tradename 29769 29775	BEXXAR
T425	tradename 30030 30036	BEXXAR
T427	tradename 30284 30290	BEXXAR
T429	tradename 30364 30370	BEXXAR
T431	activeingredient 30458 30477	radiolabeled iodine
T433	nanoparticle 30626 30644	I-131 tositumomab.
T435	tradename 30821 30827	BEXXAR
T437	tradename 30898 30904	BEXXAR
T439	tradename 31088 31098	BEXXAR.  
T441	tradename 31225 31225	
T443	adversereaction 31225 31251	Serious Allergic Reactions
T445	adversereaction 31263 31274	Anaphylaxis
T447	tradename 31327 31327	
T449	adversereaction 31327 31358	Prolonged and Severe Cytopenias
T451	tradename 31458 31458	
T453	adversereaction 31458 31472	Hypothyroidism
T455	tradename 31572 31578	BEXXAR
T457	adversereaction 31645 31656	neutropenia
T459	adversereaction 31658 31674	thrombocytopenia
T461	adversereaction 31676 31682	anemia
T463	adversereaction 31685 31695	infections
T465	adversereaction 31707 31716	pneumonia
T467	adversereaction 31718 31728	bacteremia
T469	adversereaction 31730 31740	septicemia
T471	adversereaction 31742 31752	bronchitis
T473	adversereaction 31758 31774	skin infections)
T475	adversereaction 31777 31795	infusion reactions
T477	adversereaction 31797 31805	asthenia
T479	adversereaction 31807 31812	fever
T481	adversereaction 31818 31824	nausea
T483	tradename 31952 31958	BEXXAR
T485	adversereaction 31984 32015	severe and prolonged cytopenias
T487	adversereaction 32017 32027	infections
T489	adversereaction 32039 32048	pneumonia
T491	adversereaction 32050 32060	bacteremia
T493	adversereaction 32062 32072	septicemia
T495	adversereaction 32074 32084	bronchitis
T497	adversereaction 32090 32106	skin infections)
T499	adversereaction 32108 32134	serious allergic reactions
T501	adversereaction 32146 32158	bronchospasm
T503	adversereaction 32163 32174	angioedema)
T505	adversereaction 32176 32194	infusion reactions
T507	adversereaction 32200 32218	secondary leukemia
T509	adversereaction 32224 32248	myelodysplastic syndrome
T511	tradename 32670 32676	BEXXAR
T513	indication 32718 32740	non-Hodgkin's lymphoma
T515	tradename 33959 33965	BEXXAR
T517	tradename 34085 34085	
T519	adversereaction 34085 34093	Asthenia
T521	tradename 34101 34101	
T523	adversereaction 34101 34106	Fever
T525	tradename 34116 34116	
T527	adversereaction 34116 34125	Infection
T529	tradename 34138 34138	
T531	adversereaction 34138 34142	Pain
T533	tradename 34151 34151	
T535	adversereaction 34151 34157	Chills
T537	tradename 34166 34166	
T539	adversereaction 34166 34174	Headache
T541	tradename 34184 34184	
T543	adversereaction 34184 34198	Abdominal pain
T545	tradename 34208 34208	
T547	adversereaction 34208 34217	Back pain
T549	tradename 34226 34226	
T551	adversereaction 34226 34236	Chest pain
T553	tradename 34245 34245	
T555	adversereaction 34245 34254	Neck pain
T557	tradename 34293 34293	
T559	adversereaction 34293 34304	Hypotension
T561	tradename 34312 34312	
T563	adversereaction 34312 34326	Vasodilatation
T565	tradename 34360 34360	
T567	adversereaction 34360 34366	Nausea
T569	tradename 34376 34376	
T571	adversereaction 34376 34384	Vomiting
T573	tradename 34393 34393	
T575	adversereaction 34393 34401	Anorexia
T577	tradename 34410 34410	
T579	adversereaction 34410 34418	Diarrhea
T581	tradename 34427 34427	
T583	adversereaction 34427 34439	Constipation
T585	tradename 34447 34447	
T587	adversereaction 34447 34456	Dyspepsia
T589	tradename 34493 34493	
T591	adversereaction 34493 34507	Hypothyroidism
T593	tradename 34515 34516	 
T595	adversereaction 34516 34551	Metabolic and Nutritional Disorders
T597	tradename 34560 34560	
T599	adversereaction 34560 34576	Peripheral edema
T601	tradename 34585 34585	
T603	adversereaction 34585 34596	Weight loss
T605	tradename 34640 34640	
T607	adversereaction 34640 34647	Myalgia
T609	tradename 34661 34661	
T611	adversereaction 34661 34674	Arthralgia 10
T613	tradename 34704 34704	
T615	adversereaction 34704 34713	Dizziness
T617	tradename 34722 34722	
T619	adversereaction 34722 34732	Somnolence
T621	tradename 34769 34769	
T623	adversereaction 34769 34784	Cough increased
T625	tradename 34793 34793	
T627	adversereaction 34793 34804	Pharyngitis
T629	tradename 34813 34813	
T631	adversereaction 34813 34820	Dyspnea
T633	tradename 34829 34829	
T635	adversereaction 34829 34837	Rhinitis
T637	tradename 34847 34847	
T639	adversereaction 34847 34856	Pneumonia
T641	tradename 34893 34893	
T643	adversereaction 34893 34897	Rash
T645	tradename 34910 34910	
T647	adversereaction 34910 34918	Pruritus
T649	tradename 34927 34927	
T651	adversereaction 34927 34935	Sweating
T653	tradename 36450 36451	 
T655	adversereaction 36451 36483	Prolonged and Severe Cytopenias:
T657	tradename 36838 36839	 
T659	adversereaction 36839 36850	Infections:
T661	adversereaction 36986 36995	pneumonia
T663	adversereaction 36997 37007	bacteremia
T665	adversereaction 37010 37020	septicemia
T667	adversereaction 37022 37032	bronchitis
T669	adversereaction 37038 37094	skin infections. Allergic (Hypersensitivity) Reactions:
T671	adversereaction 37182 37199	allergic reaction
T673	adversereaction 37201 37213	facial edema
T675	adversereaction 37215 37246	injection site hypersensitivity
T677	adversereaction 37249 37270	anaphylactic reaction
T679	adversereaction 37272 37283	laryngismus
T681	adversereaction 37289 37304	serum sickness.
T683	adversereaction 37342 37360	Infusion reactions
T685	adversereaction 37371 37376	fever
T687	adversereaction 37378 37384	rigors
T689	adversereaction 37388 37394	chills
T691	adversereaction 37397 37405	sweating
T693	adversereaction 37407 37418	hypotension
T695	adversereaction 37420 37427	dyspnea
T697	adversereaction 37429 37441	bronchospasm
T699	adversereaction 37447 37453	nausea
T701	tradename 37724 37725	 
T703	adversereaction 37725 37749	Myelodysplastic Syndrome
T705	adversereaction 37756 37775	Secondary Leukemia:
T707	nanoparticle 39643 39655	tositumomab.
T709	indication 40198 40220	Non-Hodgkin's Lymphoma
T711	tradename 40235 40241	BEXXAR
T713	indication 40562 40584	non-Hodgkin's lymphoma
T715	tradename 40602 40608	BEXXAR
T717	tradename 41026 41032	BEXXAR
T719	tradename 41221 41227	BEXXAR
T721	nanoparticle 41694 41705	tositumomab
T723	nanoparticle 41709 41731	I-131 499 tositumomab.
T725	tradename 41869 41875	BEXXAR
T727	tradename 41996 42002	BEXXAR
T729	activeingredient 42210 42215	I-131
T731	tradename 42290 42296	BEXXAR
T733	tradename 42407 42413	BEXXAR
T735	nanoparticle 42608 42619	tositumomab
T737	tradename 42870 42876	BEXXAR
T739	tradename 43014 43020	BEXXAR
T741	tradename 43113 43119	BEXXAR
T743	tradename 43227 43233	BEXXAR
T745	tradename 43429 43435	BEXXAR
T747	tradename 43745 43751	BEXXAR
T749	tradename 43937 43943	BEXXAR
T751	tradename 44191 44197	BEXXAR
T753	tradename 44277 44283	BEXXAR
T755	activeingredient 44424 44429	I-131
T757	tradename 44435 44441	BEXXAR
T759	activeingredient 44648 44653	I-131
T761	tradename 44671 44677	BEXXAR
T763	tradename 44960 44966	BEXXAR
T765	tradename 45011 45017	BEXXAR
T767	nanoparticle 45077 45088	tositumomab
T769	nanoparticle 45132 45150	I-131 tositumomab.
T771	tradename 45152 45152	
T773	nanoparticle 45152 45163	Tositumomab
T775	nanoparticle 45310 45321	tositumomab
T777	molecularweight 45325 45332	150 kD.
T779	tradename 45335 45335	
T781	nanoparticle 45335 45346	Tositumomab
T783	routeofadministration 45493 45504	intravenous
T785	inactiveingredient 45556 45563	maltose
T787	inactiveingredient 45575 45590	sodium chloride
T789	inactiveingredient 45600 45609	phosphate
T791	inactiveingredient 45619 45638	potassium hydroxide
T793	inactiveingredient 45644 45649	Water
T795	nanoparticle 45701 45718	I-131 tositumomab
T797	nanoparticle 45722 45733	tositumomab
T799	activeingredient 45755 45766	Iodine-131.
T801	nanoparticle 45767 45784	I-131 tositumomab
T803	nanoparticle 45865 45882	I-131 tositumomab
T805	inactiveingredient 45909 45922	ascorbic acid
T807	inactiveingredient 45937 45944	maltose
T809	inactiveingredient 45980 45987	maltose
T811	inactiveingredient 46027 46035	povidone
T813	inactiveingredient 46058 46078	sodium 568 chloride.
T815	activeingredient 46158 46180	Iodine-131: Iodine-131
T817	activeingredient 46435 46445	Iodine-131
T819	activeingredient 46646 46656	Iodine-131
T821	activeingredient 46822 46833	Iodine-131:
T823	tradename 47079 47079	
T825	activeingredient 47079 47090	Tositumomab
T827	indication 47296 47320	non-Hodgkin's lymphomas.
T829	tradename 47431 47437	BEXXAR
T831	tradename 47900 47906	BEXXAR
T833	tradename 48577 48583	BEXXAR
T835	nanoparticle 48695 48712	I-131 tositumomab
T837	dose 48731 48737	475-mg
T839	dose 48918 48924	485 mg
T841	nanoparticle 48928 48939	tositumomab
T843	indication 48961 48984	non-Hodgkin's lymphomas
T845	clearance 48989 48999	68.2 mg/hr
T847	clearance 49008 49032	30.2 to 611 260.8 mg/hr)
T849	indication 49687 49709	non-Hodgkin's lymphoma
T851	eliminationhalflife 49714 49722	67 hours
T853	eliminationhalflife 49731 49747	28 to 115 hours)
T855	activeingredient 49766 49776	Iodine-131
T857	tradename 50193 50199	BEXXAR
T859	activeingredient 50292 50304	Iodine I-131
T861	tradename 50368 50374	BEXXAR
T863	tradename 50534 50540	BEXXAR
T865	tradename 51856 51862	BEXXAR
T867	indication 52512 52534	non-Hodgkin's lymphoma
T869	tradename 52811 52817	BEXXAR
T871	nanoparticle 53423 53434	tositumomab
T873	nanoparticle 53562 53580	I-131 tositumomab
T875	nanoparticle 53863 53874	tositumomab
T877	nanoparticle 54022 54041	677 131 tositumomab
T879	tradename 54169 54169	
T881	nanoparticle 54169 54181	Tositumomab:
T883	nanoparticle 54223 54234	tositumomab
T885	nanoparticle 54355 54366	tositumomab
T887	tradename 54505 54505	
T889	nanoparticle 54505 54523	I-131 tositumomab:
T891	nanoparticle 54539 54556	I-131 tositumomab
T893	nanoparticle 54706 54723	I-131 tositumomab
T895	tradename 54832 54832	
T897	nanoparticle 54832 54849	I-131 tositumomab
T899	tradename 55849 55855	BEXXAR
T901	tradename 56092 56098	BEXXAR
T903	tradename 56477 56483	BEXXAR
T905	tradename 56589 56595	BEXXAR
T907	tradename 56664 56670	BEXXAR
T909	company 56700 56716	GlaxoSmithKline.
T911	company 56792 56807	GlaxoSmithKline
T913	company 56879 56895	GlaxoSmithKline.
